The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

Topline data were announced from two phase 3 trials evaluating ulixacaltamide in patients with essential tremor.

Imagine you are a security guard in one of those casino heist movies where your ability to recognize an emerging crime will ...

Now, by analyzing thousands of proteins found in the blood, scientists at UC San Francisco have created the clearest picture ...

A genetic testing company has opened a new patient service center in Carlisle. Texas-based Natera Inc. opened the 2,448-square-foot center at 850 Walnut Bottom Road. Natera provides genetic testing in ...

Capsule sponge-based surveillance could be used in lieu of endoscopy for low-risk Barrett esophagus (BE) surveillance, a prospective multisite UK study found. The biomarker risk panel collected by the ...

The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment called Zegfrovy. The U.S. Food and Drug Administration (FDA) has approved ...

Stress testing results—no matter the modality used to obtain them—predict prognosis among patients with stable, moderate-to-severe CAD, new data from the ISCHEMIA trial suggest. The study, published ...

Cancer Research UK-funded scientists at the University of Cambridge, in collaboration with the Spanish National Cancer Research Centre (CNIO) and Cambridge-based startup Tailor Bio, have created a ...

Genetic testing could prevent deaths tied to chemotherapy drugs like 5-FU, yet testing isn’t standard. Advocates demand change to save lives. Miami Herald File JoEllen Zembruski-Ruple, while in the ...

Dong Chen, MD, PhD, discusses how AI has changed the landscape for genomic testing and patient management. AI has truly revolutionized healthcare, profoundly enhancing both patient management and the ...